FDA approves Bayer’s Gadavist injection Approvals, Blood Vessels, Contrast Agents, Coronary Artery Disease (CAD), Diagnostic Tools, FDA, FDA/Regulatory, Heart Attacks, rest) The FDA approved Gadavist for use in cardiac magnetic resonance imaging to assess myocardial perfusion and late gadolinium enhancement in adults with known or suspected CAD. Read more July 15, 2019/by PR Newswire https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png 0 0 PR Newswire https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png PR Newswire2019-07-15 10:00:172019-07-15 13:24:44FDA approves Bayer's Gadavist injection
